Renasant Bio

Berkeley, CA · Founded 2022 · Privately Held (backing)

Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. Renasant Bio is based in Berkeley, CA and was founded in 2022. It was valued at $78 million at its seed round in Jun 2025, the last priced event on record. It has raised $55.5 million across 2 recorded rounds; the latest was a $30 million early-stage round in Jun 2025.

PMV mark · valuation
$78.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$55.5M
Last round
Early Stage VC
Jun 2025
Cap table — not yet on record

Renasant Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Renasant Bio with a free account
  • ·Watch Renasant Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Renasant Bio

Where does Renasant Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Renasant Bio's 2 recorded funding rounds.